Neurologia 

Pagina 1 di 41
1 2 3 4 5 6 7 8 9 10 ... > >>
  • Prospects for Minocycline Neuroprotection

    Minocycline is a clinically available antibiotic and anti-inflammatory drug that also demonstrates neuroprotective properties in a variety of experimental models of neurological diseases. There have thus far been more than 300 publications on minocycline neuroprotection including a growing number of human studies. Our objective is to critically review the biological basis and translational potential of this action of minocycline on the nervous system.

    Archives of Neurology (Neurologia) - Mar, 31 Agosto 2010
    http://archneur.ama-assn.org/

  • Biopolar child: 'Nobody was on my side'

    Mental health professionals say that more children are receiving diagnoses for bipolar disorder, and at younger ages. This is a serious brain disorder that may include episodes of mania and depression, intense excitement and even suicidal behavior.

    CNN.com (Neurologia) - Mar, 31 Agosto 2010
    http://www.cnn.com

  • Why are drug trials in Alzheimer's disease failing?

    Last week, semagacestat added itself to the phase 3 scrapheap of other disease-modifying hopefuls for Alzheimer's disease. This drug is a γ-secretase inhibitor of the final step in amyloid-β protein synthesis, aggregates of which form plaques, the hallmark of the disease.

    The Lancet (Neurologia) - Mar, 31 Agosto 2010
    http://www.thelancet.com

  • Education lowers dementia risk

    Professor Carol Brayne explains finding that suggest early education helps people compensate against dementia in later life

    BBC News (Neurologia) - Lun, 26 Luglio 2010
    http://news.bbc.co.uk

  • Prevalence of Huntington's Disease Underestimated

    In the United Kingdom, the actual number of people with Huntington's does not support previous population estimates; more research is needed.

    Medscape (Neurologia) - Lun, 26 Luglio 2010
    http://www.medscape.com

  • Take an Alzheimer's test?

    Now that there are tests in the works for early detection of brain injury due to Alzheimer's, children of parents with Alzheimer's ponder whether they would want to know their risk.

    CNN.com (Neurologia) - Gio, 22 Luglio 2010
    http://www.cnn.com

  • Obstructive Sleep Apnea Underestimated in Patients With Atrial Fibrillation

    obstructive sleep apnea in patients with atrial fibrillation who could benefit from treatment of the sleep disorder.

    Medscape (Neurologia) - Gio, 22 Luglio 2010
    http://www.medscape.com

  • Therapy of Recent-Onset Cervical Radiculopathies

    The onset of a cervical radiculopathy is characteristic: pain originated in the neck and irradiated to the upper limb, with a sensitive and motor deficit corresponding to the spinal root at issue. In general, the problem spontaneously clears up within 6 weeks, but in this period, pain intensity can become severe and invalidating, so the proposed treatments are various.

    MedNews (Neurologia) - Mer, 14 Luglio 2010
    http://mn.medsurfnews.com/

  • Beyond Vitamin Status:Is There a Role for Vitamin D in Parkinson Disease?

    Two years ago, Newmark and Newmark hypothesized that insufficient vitamin D could play a role in the pathogenesis of Parkinson disease (PD). The study by Knekt et al in this issue of the Archives is the first longitudinal analysis of vitamin D status as a risk of incident PD and examines a cohort of more than 3000 participants from the Mini-Finland Health Survey.

    Archives of Neurology (Neurologia) - Mer, 14 Luglio 2010
    http://archneur.ama-assn.org/

  • When Does Parkinson Disease Start?

    There is convincing evidence that the Parkinson disease neurodegenerative process begins many years before the onset of motor manifestations. Initial estimates based on nigral neuropathological findings or striatal dopamine imaging suggested a 5- to 6-year preclinical period. However, more recent evidence of Lewy body pathology in other neuronal populations preceding nigral involvement suggests that the preclinical phase may be much longer. Epidemiologic studies of nonmotor manifestations, such as constipation, anxiety disorders, rapid eye movement sleep behavior disorder (RBD), and anemia, suggest that the preclinical period extends at least 20 years before the motor manifestations. Olfactory impairment and depression may also precede the onset of motor manifestations; however, the lag time may be shorter. Recognition of a nonmotor preclinical phase spanning 20 or more years should guide the search for predictive biomarkers and the identification of risk or protective factors for Parkinson disease.

    Archives of Neurology (Neurologia) - Mer, 14 Luglio 2010
    http://archneur.ama-assn.org/

1 2 3 4 5 6 7 8 9 10 ... > >>
Pagina 1 di 41